Andrew Seth Sandler - 05 Jan 2023 Form 4 Insider Report for ALPINE IMMUNE SCIENCES, INC.

Reporting relationship: Chief Medical Officer
Issuer ticker: N/A
Reported as of: 05 Jan 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Jan 2023, 18:32:19 UTC
Prior SEC filing: 07 Oct 2022
Next SEC filing: 05 Jan 2024
Source filing: View source filing
Reporting owner signature: /s/ James Paul Rickey, attorney-in-fact

Key filing fact

Andrew Seth Sandler filed Form 4 for ALPINE IMMUNE SCIENCES, INC. on 05 Jan 2023.

Key facts

This page summarizes Andrew Seth Sandler's Form 4 filing for ALPINE IMMUNE SCIENCES, INC..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 05 Jan 2023, 18:32.

Change

Previous filing in this sequence was filed on 07 Oct 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ALPN transaction Derivative

Stock Option (Right to buy)

Award

Transaction value: $0
Shares: +50,000
Change %
Price: $0.000000
Shares after: 50,000
Date: 05 Jan 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,000
Exercise price: $7.24
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant.

Footnote F2

One-fourth (1/4th) of the Shares subject to the Option will vest on January 4, 2024, and one thirty-sixth (1/36th) of the remaining Shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to be a service provider through each such date.